Ignite Creation Date:
2024-05-06 @ 6:20 PM
Last Modification Date:
2024-10-26 @ 2:46 PM
Study NCT ID:
NCT05625087
Status:
RECRUITING
Last Update Posted:
2024-06-24
First Post:
2022-11-14
Brief Title:
Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive HR Non-HER2 Expressing HER2- Metastatic Breast Cancer as a Tool to Select Those Who May Benefit From the Next Course of Fulvestrant in Combination With Alpelisib or Ribociclib
Sponsor:
UNICANCER
Organization:
UNICANCER